» Articles » PMID: 39129008

The Spatial-temporal Distribution of Hepatitis B Virus Infection in China,2006-2018

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2024 Aug 11
PMID 39129008
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Hepatitis B is a liver disease caused by Hepatitis B virus (HBV) infection and is highly prevalent in China. To better understand the epidemiological characteristics of hepatitis B in China and develop effective disease control strategies, we employed temporal and spatial statistical methods.

Methods: We obtained HBV incidence data from the Public Health Science Data Center of the Chinese Center for Disease Control and Prevention for the years 2006 to 2018. Using Geographic Information System (GIS) and SaTScan scanning technology, we conducted spatial autocorrelation analysis and spatiotemporal scan analysis to create a map and visualize the distribution of hepatitis B incidence.

Results: While hepatitis B incidence rebounded in 2011 and 2017, the overall incidence in China decreased.In the trend analysis by item, the incidence varies from high to low. The global spatial autocorrelation analysis revealed a clustered distribution, and the Moran index analysis of spatial autocorrelation within local regions identified five provinces as H-H clusters (hot spots), while one province was an L-L cluster (cold spot). Spatial scan analysis identified 11 significant spatial clusters.

Conclusions: We found significant clustering in the spatial distribution of hepatitis B incidence and positive spatial correlation of hepatitis B incidence in China. We also identified high-risk times and regional clusters of hepatitis B incidence.

References
1.
Gao J, Zhang Z, Wang Z, Bian J, Wang J, Jiang W . [Spatial distribution characteristics of iodine in drinking water in Shandong province between year 2008 and 2010]. Zhonghua Yu Fang Yi Xue Za Zhi. 2013; 47(1):18-22. View

2.
Dou X, Lyu J, Feng L, Yan B, Feng Y, Zhao X . [Analysis of capability to pertussis etiology and serological diagnosis for GradeⅡ and Ⅲmedical institutions in Shandong Province in 2018]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021; 55(6):727-731. DOI: 10.3760/cma.j.cn112150-20210316-00255. View

3.
Wang F, Fan J, Zhang Z, Gao B, Wang H . The global burden of liver disease: the major impact of China. Hepatology. 2014; 60(6):2099-108. PMC: 4867229. DOI: 10.1002/hep.27406. View

4.
Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

5.
Liu Z, Wang Y, Wang W . [Study on changes in hepatitis B incidence in China, 1990-2017]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021; 42(4):613-619. DOI: 10.3760/cma.j.cn112338-20201026-01281. View